Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2023-08-10

FDA Approved: ZEPOSIA 7-DAY STARTER PACK — Supplemental Application (Celgene Corporation)

View source ↗

Summary

The FDA approved a supplemental submission to add a 7-day starter pack for Zeposia (ozanimod hydrochloride) to initiate therapy. This updates the labeling to in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zeposia (ozanimod hydrochloride)

Snippet

SUPPL AP for ZEPOSIA 7-DAY STARTER PACK (OZANIMOD HYDROCHLORIDE)